Status:
COMPLETED
Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Opioid Induced Respiratory Depression
Eligibility:
All Genders
1+ years
Brief Summary
Opioids are the mainstay of analgesia in hospitalized children but opioid therapy is associated with life-threatening respiratory depression requiring antagonism with naloxone. Hence, it is hypothesiz...
Eligibility Criteria
Inclusion
- any gender, age or race
- administered naloxone for opioid induced respiratory depression
Exclusion
- Any one who did not require naloxone for opioid induced respiratory depression
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT01860885
Start Date
August 1 2012
End Date
May 1 2013
Last Update
May 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229